Profile Summary

Medical qualification : 

  • MBBS, MD, DM, ECMO, PDCR
  • M.B.B.S. - B. J. Medical College Pune - 1998-2002,M U H S ,Nashik
  • M D Medicine - Govt. medical college, Aurangabad - May 2008,Dr Babasaheb Ambedkar Marathwada University , Aurangabad
  • D M Medical Oncology - Tata Memorial Centre, Mumbai - July 2012, Homi Bhabha National University, Mumbai
  • ECMO - European Society of Medical Oncology - Sept 2012

 

Designation at JHRC:  consultant - Medical oncology

Special interest:

  • Breast cancer
  • G.I. Malignancies
  • Ovarian cancer
  • Lung cancer 
  • Pediatric leukemia and lymphomas 
  • Pediatric solid tumors
  • Molecular & Translational research

Introduction:

Dr Bhosale is associate with Jaslok Hospital as Medical Oncologist. He completed his medical oncology from Tata Memorial Centre. He was awarded the 1st prize for designing trial "Adjuvant chemotherapy in node positive hormone receptor positive breast cancer." ICON Nagpur , 2011.

Awards & Publications : 

Fellowships:

  •  UAE cancer Congress 2013 & 2014 invited as Faculty
  •  ESMO(European Society of Medical Oncology) Preceptorship on Lung Cancer Singapoore 2014
  •  ESMO(European Society of Medical Oncology) Preceptorship on Prostate Cancer Prague 2015
  •  ESMO Translational research Fellowship 2015 Vienna
  • Invited as national speaker in various international and national meetings held across India


 

Publications:

Abstracts published in various international and national journals:

  •  Bharatsinha Bhosale, Pankaj Dwivedi, Vijay Patil, M Vamshi Krishna, Ravi T, Nitin Inamdar, Ruprekha Hegade, Tushar Vora, Girish Chinnaswamy, P kurkure, S D Banavali. Is vitamin D deficiency associated with advanced cancers in children? .(Accepted: Pediatric Blood and Cancer,DOI 10.1002/pbc)
  •  Pankaj Dwivedi, Bharat Bhosale, Ravi T, Saurabh Radhakrishnan, Tushar Vora, Girish Chinnaswamy, Brijesh Arora, Shripad Banavali.Single dose/single vial (1.5mg) rasburicase in the management of pediatric patients with hyperurecimia and/ or tumor lysis syndrome. Experience from Tata Memorial Centre.(Accepted as an abstract in Pediatric Blood and Cancer, Oct 2012)
  • V. Naronha, K Prabhash, B Bhosale, A. Joshi. AOS28 High pathological response rate with docetaxel plus cisplatin plus fluorouracil induction regimen in oesophageal cancer: Initial experience. European Journal of Cancer; Volume 48, Supplement 4, Page S13, April 2012
  •   B. Bhosale, Ravi T, N Kumar, S Radhakrishnan, B Bagal, A Joshi, S Kanan, H Menon, M Sengar, R Nair, N Khattry. Long term results of autologous transplants for lymphomas from Tata Memorial Center.Indian J Hematol Blood Transfus 2011; 27(4):185-289.(Abstract: P127)
  • R. Thippeswamy, L. Mathew, B. Bhosale, N. Kumar, S. Kannan, A. Joshi, V. Rangarajan, N. Khattry. LACE: A conditioning regimen for patients with lymphoma undergoing autologous transplant. J Clin Oncol 29: 2011 (suppl; abstr 6591).
  •  S.Mittal, Ravi T, DK Rajamanickam, A Gokarn, B Bhosale, S Kannan, B Bagal, J Gawande, R Nair, N Khattry.Incidence, Risk factors and outcome of Engraftment Fever Post Autologus Transplant for Lymphomas. Indian J Hematol Blood Transfus 2011; 27(4):185-289.(Abstract: P133)
  •  Navin Khattry, Reetu Jain, Ravi Tippeswamy, Adwaita Gore, Bharat Bhosale, Sadhana Kannan, Amit Joshi, Reena Nair, Tapan Saikia- on behalf of Indian Society of Oncology Group (ISOG).Comparison of Toxicity and Outcomes of BCNU-containing Conditioning Regimens vs LACE in Lymphoma Transplants: A Retrospective Multicenter Analysis. Blood,2011; Vol.118 ,No.21.
  • V. Ostwal, N. Ghadyalpatil, K. Prabhash, H. Menon, R. Nair, M. Sengar, V. Noronha, S. Biswas, B. Bhosale, S. Banavali. Reactivation of latent viral hepatitis infection in patients of chronic myeloid leukemia treated with imatinib mesylate: Experience from a tertiary cancer center in India. J Clin Oncol 28:15s, 2010 (suppl; abstr 6593).

Memberships :

Memberships In Scientific Societies:

  • ESMO: European Society for Medical Oncology
  • ICON: Indian Cooperative Oncology Network
  •  MHG : Mumbai Hematology Group